Recombinant protein, adjuvanted(GSK)

N/A

Report date: 2024/12/11 10:41:56

Base Information

Drug NameRecombinant protein, adjuvanted(GSK)
Drug Alias NameGSK-4106647-AHPV9-AS04GSK-4106647AGSK4106647A
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPapillomavirus InfectionsCondylomata Acuminata
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc
Inactive CompaniesN/A
Active IndicationsPapillomavirus InfectionsCondylomata Acuminata
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A